What is the main business of Okadel?

The main business activity of Okadel focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 26, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Naddnieprzańska 26, 04-205 Warszawa.

What is the share capital?

The share capital of the company is PLN 47,000 (approx. $12,696).

What period do the latest financial data cover?

The latest available financial statement covers the period from September 26, 2022 to December 31, 2023.

How much revenue was generated?

The company reported a revenue of $12,510,872 in 2023.

Is the company profitable?

Yes, the company recorded a net profit of $4,343,063 in 2023.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $6,450,510 in 2023, representing 96% of all operating expenses.

Okadelsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-09-26

Share capital

47,000.00 PLN

Registered address

ul. Naddnieprzańska 26/B, 04-205 Warszawa, Poland

Electronic delivery address

AE:PL-77941-86949-GWIIR-20

Financials

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2023, 52 days late).

2024not filed
202305/09/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 12.51mMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD 4.34mMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 6.73mMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 5.80mMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Ganna Gorbachova – President of the Management Board

Manner of representation

In the case of a one-person management board, the President of the Management Board has the right to represent the company independently; in the case of a multi-member management board, each member of the management board is authorised to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Oksana Greyts	470	$12,695.84	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-10-12.

Bank Pekao SA
02 1240 1040 1978 0011 1903 6023
Bank Pekao SA
45 1240 1040 1787 0011 1903 6166
Bank Pekao SA
77 1240 1040 1111 0011 1903 5925

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Nov 26, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$17$17	E.ON Polska S.A.

Competitors

Name	Revenue	Website
Synkmedsp. z o.o.	$20,634,200.47	synkmed.pl
Intimexsp. z o.o. + limited partnership	$18,994,512.90	intimex.com.pl
Medif sp. z o.o.sp. k.	$13,126,958.83	medif.com
PromedS.A.	$12,643,674.56	promed.com.pl
AO East Europesp. z o.o.	$12,156,227.53	aoeasteurope.pl
MassmedicaS.A.	$8,216,274.00	massmedica.com
SPA Landsp. z o.o.	$4,782,973.66	hydrafacial.pl
Hair Partnerssp. z o.o.	$4,347,484.74	hairpartners.pl
Balmed Polandsp. z o.o.	$3,140,735.80	balmed.it
Medikon Polskasp. z o.o.	$2,666,944.24	medikon.pl

Change history

Date	Event
2025-10-17	Address change (Aleja "solidarności" 117/207, 00-140, Warszawa → Ul. Naddnieprzańska 26/B, 04-205, Warszawa)
2022-09-26	Entered in the register

FAQ

Last updated: 2026-10-07